Gara Jalqabaatti › Baayyee Ulfaataa › Arizona › Phoenix
Qorannoo klinikaalii Baayyee Ulfaataa Phoenix, AZ keessatti
Qorannoo 15 Baayyee Ulfaataa f Phoenix fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Absolute Clinical Research, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Namoota walitti qabaa jiraSadarkaa 3
- RIO Clinical Trials - Phoenix, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Elite Clinical Studies, LLC, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-2 Clinical Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-1 Clinical Site, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Namoota walitti qabaa jiraSadarkaa 2
- Helios Clinical Research - Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
- ACCOMPLISH-2 Research Site, Phoenix
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 2
- Synexus Clinical Research US, Inc., Phoenix
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Namoota walitti qabaa jiraSadarkaa 4
- Medical Dermatology Specialists, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kailera Clinical Site, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
Namoota walitti qabaa jiraQorannoo ilaalaa
- Exponent Phoenix, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Namoota walitti qabaa jiraSadarkaa 3
- ACCOMPLISH-1 Research Site, Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
Namoota walitti qabaa jiraSadarkaa 3
- The University of Arizona College of Medicine- Phoenix, Phoenix
Qorannoo Baayyee Ulfaataa magaalota biroo keessatti
- San Antonio, TXQorannoo 34
- Houston, TXQorannoo 33
- Chicago, ILQorannoo 29
- Orlando, FLQorannoo 27
- Las Vegas, NVQorannoo 23
- Miami, FLQorannoo 23
- Dallas, TXQorannoo 20
- Atlanta, GAQorannoo 20
- New York City, NYQorannoo 19
- Jacksonville, FLQorannoo 19
- Washington, DCQorannoo 19
- Austin, TXQorannoo 18
Qorannoo biroo Phoenix keessatti
- Saree OljooQorannoo 25
- Kansarii ColorectalQorannoo 25
- ObesityQorannoo 22
- Kansara MetastatikiiQorannoo 20
- Kansara Qara'a Non-Small CellQorannoo 20
- Cufama OnneeQorannoo 18
- Saree (Gosoota Hunda)Qorannoo 17
- Kansarii ProstateQorannoo 17
- Dhibee Onneessaa fi DhiigaQorannoo 16
- Myeloma Baay’eeQorannoo 16
- Kansarii PancreasQorannoo 16
- Dhukkubaa AlzheimerQorannoo 15
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.